Esperion Therapeutics, Inc. 0ET.F Stock
Esperion Therapeutics, Inc. Price Chart
Esperion Therapeutics, Inc. 0ET.F Financial and Trading Overview
| Esperion Therapeutics, Inc. stock price | 2.04 EUR |
| Previous Close | 1.32 EUR |
| Open | 1.24 EUR |
| Bid | 1.23 EUR x N/A |
| Ask | 1.27 EUR x N/A |
| Day's Range | 1.24 - 1.24 EUR |
| 52 Week Range | 0.97 - 8.79 EUR |
| Volume | 7.88K EUR |
| Avg. Volume | 229 EUR |
| Market Cap | 117.82M EUR |
| Beta (5Y Monthly) | 0.145774 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.89 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 42.45 EUR |
0ET.F Valuation Measures
| Enterprise Value | 467.95M EUR |
| Trailing P/E | N/A |
| Forward P/E | -0.22293906 |
| PEG Ratio (5 yr expected) | -0.07 |
| Price/Sales (ttm) | 1.4551749 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 5.779 |
| Enterprise Value/EBITDA | -2.534 |
Trading Information
Esperion Therapeutics, Inc. Stock Price History
| Beta (5Y Monthly) | 0.145774 |
| 52-Week Change | -73.28% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 8.79 EUR |
| 52 Week Low | 0.97 EUR |
| 50-Day Moving Average | 1.27 EUR |
| 200-Day Moving Average | 5.03 EUR |
0ET.F Share Statistics
| Avg. Volume (3 month) | 229 EUR |
| Avg. Daily Volume (10-Days) | 400 EUR |
| Shares Outstanding | 94.71M |
| Float | 83.65M |
| Short Ratio | N/A |
| % Held by Insiders | 0.45% |
| % Held by Institutions | 97.36% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -294.74% |
| Operating Margin (ttm) | -228.63% |
| Gross Margin | -94.50% |
| EBITDA Margin | -228.10% |
Management Effectiveness
| Return on Assets (ttm) | -38.91% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 80.97M EUR |
| Revenue Per Share (ttm) | 1.14 EUR |
| Quarterly Revenue Growth (yoy) | 29.19% |
| Gross Profit (ttm) | -70419000 EUR |
| EBITDA | -184688992 EUR |
| Net Income Avi to Common (ttm) | -238647008 EUR |
| Diluted EPS (ttm) | -3.13 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 162.34M EUR |
| Total Cash Per Share (mrq) | 1.71 EUR |
| Total Debt (mrq) | 513.22M EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 2.625 |
| Book Value Per Share (mrq) | -3.779 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -190192992 EUR |
| Levered Free Cash Flow (ttm) | -149338496 EUR |
Profile of Esperion Therapeutics, Inc.
| Country | Germany |
| State | MI |
| City | Ann Arbor |
| Address | 3891 Ranchero Drive |
| ZIP | 48108 |
| Phone | 734 887 3903 |
| Website | https://www.esperion.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 199 |
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration agreement with Daiichi Sankyo Europe GmbH; and Serometrix to in-license its oral, small molecule PCSK9 inhibitor program. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.
Q&A For Esperion Therapeutics, Inc. Stock
What is a current 0ET.F stock price?
Esperion Therapeutics, Inc. 0ET.F stock price today per share is 2.04 EUR.
How to purchase Esperion Therapeutics, Inc. stock?
You can buy 0ET.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Esperion Therapeutics, Inc.?
The stock symbol or ticker of Esperion Therapeutics, Inc. is 0ET.F.
Which industry does the Esperion Therapeutics, Inc. company belong to?
The Esperion Therapeutics, Inc. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Esperion Therapeutics, Inc. have in circulation?
The max supply of Esperion Therapeutics, Inc. shares is 185.05M.
What is Esperion Therapeutics, Inc. Price to Earnings Ratio (PE Ratio)?
Esperion Therapeutics, Inc. PE Ratio is now.
What was Esperion Therapeutics, Inc. earnings per share over the trailing 12 months (TTM)?
Esperion Therapeutics, Inc. EPS is -1.89 EUR over the trailing 12 months.
Which sector does the Esperion Therapeutics, Inc. company belong to?
The Esperion Therapeutics, Inc. sector is Healthcare.